University of Washington medtech spinout Perimatics will develop an anaesthesia monitoring platform that could improve care outcomes.
Perimatics, a US-based medtech developer, was spun out from University of Washington last week with $1m in seed funding from data analytics and business consultant Winigent, GeekWire reported on Monday.
The university’s tech transfer arm, CoMotion, has granted Perimatics the licence for Smart Anaesthesia Manager (Sam), a platform for monitoring surgical anaesthetic patients in real time – before, during and after their procedures.
The product exploits predictive analytics and business intelligence to improve care outcomes and efficiency. University trials suggest Sam could reduce gaps in blood pressure monitoring from 192 minutes to 34 minutes.
Perimatics is based on work by Bala Nair, research associate professor in Washington’s Department of Anaesthesiology and Pain Medicine and chief solution architect of the new business. Winigent’s founder, Kalyani Velagapudi, has been appointed chief executive.
Jim Brisimitzis, general manager of Microsoft for Startups, an incubator scheme run by software company Microsoft, will act as an adviser to reflect Perimatics’ participation in the initiative.
Bala Nair said: “Sam is a proven technology tested in five hospitals with over 400,000 uses. It adds $1.2m annually to the bottom line at University of Washington Medical Centre through better patient safety, quality of care, revenue capture and waste reduction.”
Kalyani Velagapudi added: “We are excited to be licensing this technology that has such significant potential for optimising perioperative care and reducing overall healthcare costs.”
